Our portfolio

40 Active Ventures

Our portfolio consists of startups and scaleups covering a variety of industries, reflecting the broad research focus of our founding institutes. For more information about any of these ventures you can contact our investment managers.

40 results

Sort by

Developing rapid human gut microbiota analysis.

Developing bispecific antibodies as enhanced cancer immunotherapy.

Advancing new therapeutics for Type 1 Diabetes and autoimmune diseases.

Amplifying treatment of chronic autoimmune diseases.

Improving orthopedic diagnostics with advanced joint loading device and AI-based imaging technology.

Modulating immune responses with glycan-modified antigens for the treatment of Type 1 Diabetes.

Cellagenics

Scaling up therapeutic antibody production with STEP® technology.

Enhancing microscopes with low-power super-resolution imaging solutions.

Developing stool-based colorectal cancer screening for early detection.

Enhancing deep sleep through real-time, non-invasive brainwave stimulation using adaptive, science-backed algorithms.

Providing advanced defect detection for carbon composites in aerospace and wind energy.

Combining quantum computing and classical simulations for material science.

Enabling secure AI-assisted data management, analysis, visualization, sharing, and FAIR publishing.

Automating urine output monitoring for hospitalized patients.

Improving surgical skill development with the Lapron Boxtrainer, a laparoscopic training system.

GuanaRep

Repurposing the obsolete hypertension drug Guanabenz for the treatment of Vanishing White Matter.

Preventing post-surgical complications with the PURE pericardial flushing device.

Speeding up post-surgical rehabilitation with a personalized e-health recovery platform.

Improving diabetes management with the AP, a closed-loop bi-hormonal artificial pancreas.

Enabling standard spectrometers to simultaneously measure both chemical composition and particle size by integrating patented, cost-effective Optical-DOSY flow cells.

Digitizing stroke treatment development and planning with an in-silico stroke simulation platform.

Improving elderly care with Night Nurse, an AI-powered patient monitoring system.

Discovering novel antibodies for cancer and infectious disease treatments.

Using AI to restructure audio data, such as podcasts and webinars.

Advancing nanotechnology with sustainable, solvent-free nanoparticle synthesis.

OpticsFoundry

Revolutionizing optical circuit manufacturing by offering robotically assembled and modular optical circuit boards that are easy to design, order, and deploy.

Developing gene therapy solutions for heart rhythm disorders.

Developing novel treatments for Parkinson’s disease and dopamine disorders.

Developing RNA-based therapies for rare genetic heart diseases.

Reducing plastic waste and lowering CO2 emissions.

Investing in and developing molecular diagnostics for biotech innovation.

Developing portable neurophysiological research tools for EEG and behavioral studies.

Providing quantum-safe security solutions to protect organizations from future cyber threats.

Engineering antibodies to treat neurodegenerative and immune diseases.

Developing therapeutic antibodies, including the blockbuster RSV drug Nirsevimab.

Developing a painless and more accurate mammography technology for breast cancer detection.

Advancing molecular diagnostics for precision oncology and infectious diseases.

Enhancing plant growth with solar-powered nanotechnology.

Upcycling phosphate waste into sustainable industrial products.

Innovating stroke diagnosis with an AI-powered portable EEG for use inside the ambulance.

Our success stories

9 Exits

Transforming content into audio-based e-learning for on-the-go learning.

Developing local gene therapy for chronic diseases, Arthrogen utilizes viral-mediated gene transfer to treat conditions like rheumatoid arthritis.

Pioneering cancer vaccines, DCPrime leverages its DCOne® dendritic cell technology to develop innovative immunotherapies.

Boosting recovery and confidence in elderly hip fracture patients with data-driven rehabilitation technology.

Developing adaptive online learning systems.

Enhancing patient care with AI-driven radiology solutions for clinical practice.

Developing advanced machine learning and deep learning technologies, Scyfer specializes in applying these solutions across various industries, including industry, media, and healthcare.

Specializing in AI-powered audience intelligence, Sightcorp provides automated facial analysis and emotion recognition technology.

Pioneering gene therapy, uniQure develops transformative treatments using its AAV-based technology platform.

Our portfolio

Our success stories

Holdings of our founding institutes

Contact